Global Blood Serum

Blood Serum Comprehensive Study by Type (Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine), Equine, Porcine, Other), Application (Cell Culture Media, Cell Line Saving, Tissue Culture, Diagnostic Reagents) Players and Region - Global Market Outlook to 2026

Blood Serum Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Blood Serum Market?

Blood serum is the portion of plasma remaining after coagulation of blood during which process the plasma protein fibrinogen is converted to fibrin and remains behind in the clot that does not play a role in clotting. Blood serum is used in numerous diagnostic tests as well as blood typing. It includes all proteins not used in blood clotting. The factors such as High Demand for Numerous Diagnostic Tests and Increased Number of Biotechnology and Pharmaceutical Companies are driving the global blood serum market.

The market study is being classified by Type (Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine), Equine, Porcine and Other), by Application (Cell Culture Media, Cell Line Saving, Tissue Culture and Diagnostic Reagents) and major geographies with country level break-up.

Thermo Fisher Scientific (United States), Sigma-Aldrich (United States), Merck Group (Germany), Corning Inc. (United States), Biological Industries (Israel), Bovogen Biologicals (Australia), Moregate Biotech (Australia), VWR International (United States), South Pacific Sera (New Zealand) and Atlanta Biologicals, Inc. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Zhejiang Tianhang Biotechnology Co Ltd (China) and Jin Yuan Kang Industry Co., Ltd. (China).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Serum market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Blood Serum market by Type, Application and Region.

On the basis of geography, the market of Blood Serum has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • High Demand for Numerous Diagnostic Tests
  • Increased Number of Biotechnology and Pharmaceutical Companies

Market Trend
  • Increased Number of Research and Development Activities

Restraints
  • Risk of Transmission of Bloodborne Diseases

Opportunities
  • Growing Healthcare Industry Worldwide
  • Development of New Products

Challenges
  • Stringent Government Rules and Regulations


Market Leaders and some development strategies
In March 2020, Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies, has announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN.



Key Target Audience
Pharmaceutical Companies, Research Professionals, Emerging Companies and End-users

Report Objectives / Segmentation Covered

By Type
  • Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
  • Equine
  • Porcine
  • Other
By Application
  • Cell Culture Media
  • Cell Line Saving
  • Tissue Culture
  • Diagnostic Reagents
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand for Numerous Diagnostic Tests
      • 3.2.2. Increased Number of Biotechnology and Pharmaceutical Companies
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Number of Research and Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Serum, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blood Serum (Value)
      • 5.2.1. Global Blood Serum by: Type (Value)
        • 5.2.1.1. Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
        • 5.2.1.2. Equine
        • 5.2.1.3. Porcine
        • 5.2.1.4. Other
      • 5.2.2. Global Blood Serum by: Application (Value)
        • 5.2.2.1. Cell Culture Media
        • 5.2.2.2. Cell Line Saving
        • 5.2.2.3. Tissue Culture
        • 5.2.2.4. Diagnostic Reagents
      • 5.2.3. Global Blood Serum Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Blood Serum: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sigma-Aldrich (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Group (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Corning Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biological Industries (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bovogen Biologicals (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Moregate Biotech (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. VWR International (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. South Pacific Sera (New Zealand)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Atlanta Biologicals, Inc. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Serum Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blood Serum (Value)
      • 7.2.1. Global Blood Serum by: Type (Value)
        • 7.2.1.1. Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
        • 7.2.1.2. Equine
        • 7.2.1.3. Porcine
        • 7.2.1.4. Other
      • 7.2.2. Global Blood Serum by: Application (Value)
        • 7.2.2.1. Cell Culture Media
        • 7.2.2.2. Cell Line Saving
        • 7.2.2.3. Tissue Culture
        • 7.2.2.4. Diagnostic Reagents
      • 7.2.3. Global Blood Serum Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Serum: by Type(USD Million)
  • Table 2. Blood Serum Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine) , by Region USD Million (2015-2020)
  • Table 3. Blood Serum Equine , by Region USD Million (2015-2020)
  • Table 4. Blood Serum Porcine , by Region USD Million (2015-2020)
  • Table 5. Blood Serum Other , by Region USD Million (2015-2020)
  • Table 6. Blood Serum: by Application(USD Million)
  • Table 7. Blood Serum Cell Culture Media , by Region USD Million (2015-2020)
  • Table 8. Blood Serum Cell Line Saving , by Region USD Million (2015-2020)
  • Table 9. Blood Serum Tissue Culture , by Region USD Million (2015-2020)
  • Table 10. Blood Serum Diagnostic Reagents , by Region USD Million (2015-2020)
  • Table 11. South America Blood Serum, by Country USD Million (2015-2020)
  • Table 12. South America Blood Serum, by Type USD Million (2015-2020)
  • Table 13. South America Blood Serum, by Application USD Million (2015-2020)
  • Table 14. Brazil Blood Serum, by Type USD Million (2015-2020)
  • Table 15. Brazil Blood Serum, by Application USD Million (2015-2020)
  • Table 16. Argentina Blood Serum, by Type USD Million (2015-2020)
  • Table 17. Argentina Blood Serum, by Application USD Million (2015-2020)
  • Table 18. Rest of South America Blood Serum, by Type USD Million (2015-2020)
  • Table 19. Rest of South America Blood Serum, by Application USD Million (2015-2020)
  • Table 20. Asia Pacific Blood Serum, by Country USD Million (2015-2020)
  • Table 21. Asia Pacific Blood Serum, by Type USD Million (2015-2020)
  • Table 22. Asia Pacific Blood Serum, by Application USD Million (2015-2020)
  • Table 23. China Blood Serum, by Type USD Million (2015-2020)
  • Table 24. China Blood Serum, by Application USD Million (2015-2020)
  • Table 25. Japan Blood Serum, by Type USD Million (2015-2020)
  • Table 26. Japan Blood Serum, by Application USD Million (2015-2020)
  • Table 27. India Blood Serum, by Type USD Million (2015-2020)
  • Table 28. India Blood Serum, by Application USD Million (2015-2020)
  • Table 29. South Korea Blood Serum, by Type USD Million (2015-2020)
  • Table 30. South Korea Blood Serum, by Application USD Million (2015-2020)
  • Table 31. Taiwan Blood Serum, by Type USD Million (2015-2020)
  • Table 32. Taiwan Blood Serum, by Application USD Million (2015-2020)
  • Table 33. Australia Blood Serum, by Type USD Million (2015-2020)
  • Table 34. Australia Blood Serum, by Application USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Blood Serum, by Type USD Million (2015-2020)
  • Table 36. Rest of Asia-Pacific Blood Serum, by Application USD Million (2015-2020)
  • Table 37. Europe Blood Serum, by Country USD Million (2015-2020)
  • Table 38. Europe Blood Serum, by Type USD Million (2015-2020)
  • Table 39. Europe Blood Serum, by Application USD Million (2015-2020)
  • Table 40. Germany Blood Serum, by Type USD Million (2015-2020)
  • Table 41. Germany Blood Serum, by Application USD Million (2015-2020)
  • Table 42. France Blood Serum, by Type USD Million (2015-2020)
  • Table 43. France Blood Serum, by Application USD Million (2015-2020)
  • Table 44. Italy Blood Serum, by Type USD Million (2015-2020)
  • Table 45. Italy Blood Serum, by Application USD Million (2015-2020)
  • Table 46. United Kingdom Blood Serum, by Type USD Million (2015-2020)
  • Table 47. United Kingdom Blood Serum, by Application USD Million (2015-2020)
  • Table 48. Netherlands Blood Serum, by Type USD Million (2015-2020)
  • Table 49. Netherlands Blood Serum, by Application USD Million (2015-2020)
  • Table 50. Rest of Europe Blood Serum, by Type USD Million (2015-2020)
  • Table 51. Rest of Europe Blood Serum, by Application USD Million (2015-2020)
  • Table 52. MEA Blood Serum, by Country USD Million (2015-2020)
  • Table 53. MEA Blood Serum, by Type USD Million (2015-2020)
  • Table 54. MEA Blood Serum, by Application USD Million (2015-2020)
  • Table 55. Middle East Blood Serum, by Type USD Million (2015-2020)
  • Table 56. Middle East Blood Serum, by Application USD Million (2015-2020)
  • Table 57. Africa Blood Serum, by Type USD Million (2015-2020)
  • Table 58. Africa Blood Serum, by Application USD Million (2015-2020)
  • Table 59. North America Blood Serum, by Country USD Million (2015-2020)
  • Table 60. North America Blood Serum, by Type USD Million (2015-2020)
  • Table 61. North America Blood Serum, by Application USD Million (2015-2020)
  • Table 62. United States Blood Serum, by Type USD Million (2015-2020)
  • Table 63. United States Blood Serum, by Application USD Million (2015-2020)
  • Table 64. Canada Blood Serum, by Type USD Million (2015-2020)
  • Table 65. Canada Blood Serum, by Application USD Million (2015-2020)
  • Table 66. Mexico Blood Serum, by Type USD Million (2015-2020)
  • Table 67. Mexico Blood Serum, by Application USD Million (2015-2020)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Blood Serum: by Type(USD Million)
  • Table 79. Blood Serum Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine) , by Region USD Million (2021-2026)
  • Table 80. Blood Serum Equine , by Region USD Million (2021-2026)
  • Table 81. Blood Serum Porcine , by Region USD Million (2021-2026)
  • Table 82. Blood Serum Other , by Region USD Million (2021-2026)
  • Table 83. Blood Serum: by Application(USD Million)
  • Table 84. Blood Serum Cell Culture Media , by Region USD Million (2021-2026)
  • Table 85. Blood Serum Cell Line Saving , by Region USD Million (2021-2026)
  • Table 86. Blood Serum Tissue Culture , by Region USD Million (2021-2026)
  • Table 87. Blood Serum Diagnostic Reagents , by Region USD Million (2021-2026)
  • Table 88. South America Blood Serum, by Country USD Million (2021-2026)
  • Table 89. South America Blood Serum, by Type USD Million (2021-2026)
  • Table 90. South America Blood Serum, by Application USD Million (2021-2026)
  • Table 91. Brazil Blood Serum, by Type USD Million (2021-2026)
  • Table 92. Brazil Blood Serum, by Application USD Million (2021-2026)
  • Table 93. Argentina Blood Serum, by Type USD Million (2021-2026)
  • Table 94. Argentina Blood Serum, by Application USD Million (2021-2026)
  • Table 95. Rest of South America Blood Serum, by Type USD Million (2021-2026)
  • Table 96. Rest of South America Blood Serum, by Application USD Million (2021-2026)
  • Table 97. Asia Pacific Blood Serum, by Country USD Million (2021-2026)
  • Table 98. Asia Pacific Blood Serum, by Type USD Million (2021-2026)
  • Table 99. Asia Pacific Blood Serum, by Application USD Million (2021-2026)
  • Table 100. China Blood Serum, by Type USD Million (2021-2026)
  • Table 101. China Blood Serum, by Application USD Million (2021-2026)
  • Table 102. Japan Blood Serum, by Type USD Million (2021-2026)
  • Table 103. Japan Blood Serum, by Application USD Million (2021-2026)
  • Table 104. India Blood Serum, by Type USD Million (2021-2026)
  • Table 105. India Blood Serum, by Application USD Million (2021-2026)
  • Table 106. South Korea Blood Serum, by Type USD Million (2021-2026)
  • Table 107. South Korea Blood Serum, by Application USD Million (2021-2026)
  • Table 108. Taiwan Blood Serum, by Type USD Million (2021-2026)
  • Table 109. Taiwan Blood Serum, by Application USD Million (2021-2026)
  • Table 110. Australia Blood Serum, by Type USD Million (2021-2026)
  • Table 111. Australia Blood Serum, by Application USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Blood Serum, by Type USD Million (2021-2026)
  • Table 113. Rest of Asia-Pacific Blood Serum, by Application USD Million (2021-2026)
  • Table 114. Europe Blood Serum, by Country USD Million (2021-2026)
  • Table 115. Europe Blood Serum, by Type USD Million (2021-2026)
  • Table 116. Europe Blood Serum, by Application USD Million (2021-2026)
  • Table 117. Germany Blood Serum, by Type USD Million (2021-2026)
  • Table 118. Germany Blood Serum, by Application USD Million (2021-2026)
  • Table 119. France Blood Serum, by Type USD Million (2021-2026)
  • Table 120. France Blood Serum, by Application USD Million (2021-2026)
  • Table 121. Italy Blood Serum, by Type USD Million (2021-2026)
  • Table 122. Italy Blood Serum, by Application USD Million (2021-2026)
  • Table 123. United Kingdom Blood Serum, by Type USD Million (2021-2026)
  • Table 124. United Kingdom Blood Serum, by Application USD Million (2021-2026)
  • Table 125. Netherlands Blood Serum, by Type USD Million (2021-2026)
  • Table 126. Netherlands Blood Serum, by Application USD Million (2021-2026)
  • Table 127. Rest of Europe Blood Serum, by Type USD Million (2021-2026)
  • Table 128. Rest of Europe Blood Serum, by Application USD Million (2021-2026)
  • Table 129. MEA Blood Serum, by Country USD Million (2021-2026)
  • Table 130. MEA Blood Serum, by Type USD Million (2021-2026)
  • Table 131. MEA Blood Serum, by Application USD Million (2021-2026)
  • Table 132. Middle East Blood Serum, by Type USD Million (2021-2026)
  • Table 133. Middle East Blood Serum, by Application USD Million (2021-2026)
  • Table 134. Africa Blood Serum, by Type USD Million (2021-2026)
  • Table 135. Africa Blood Serum, by Application USD Million (2021-2026)
  • Table 136. North America Blood Serum, by Country USD Million (2021-2026)
  • Table 137. North America Blood Serum, by Type USD Million (2021-2026)
  • Table 138. North America Blood Serum, by Application USD Million (2021-2026)
  • Table 139. United States Blood Serum, by Type USD Million (2021-2026)
  • Table 140. United States Blood Serum, by Application USD Million (2021-2026)
  • Table 141. Canada Blood Serum, by Type USD Million (2021-2026)
  • Table 142. Canada Blood Serum, by Application USD Million (2021-2026)
  • Table 143. Mexico Blood Serum, by Type USD Million (2021-2026)
  • Table 144. Mexico Blood Serum, by Application USD Million (2021-2026)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Serum: by Type USD Million (2015-2020)
  • Figure 5. Global Blood Serum: by Application USD Million (2015-2020)
  • Figure 6. South America Blood Serum Share (%), by Country
  • Figure 7. Asia Pacific Blood Serum Share (%), by Country
  • Figure 8. Europe Blood Serum Share (%), by Country
  • Figure 9. MEA Blood Serum Share (%), by Country
  • Figure 10. North America Blood Serum Share (%), by Country
  • Figure 11. Global Blood Serum share by Players 2020 (%)
  • Figure 12. Global Blood Serum share by Players (Top 3) 2020(%)
  • Figure 13. Global Blood Serum share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 16. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 17. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sigma-Aldrich (United States) Revenue: by Geography 2020
  • Figure 19. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 21. Corning Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Corning Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Biological Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 24. Biological Industries (Israel) Revenue: by Geography 2020
  • Figure 25. Bovogen Biologicals (Australia) Revenue, Net Income and Gross profit
  • Figure 26. Bovogen Biologicals (Australia) Revenue: by Geography 2020
  • Figure 27. Moregate Biotech (Australia) Revenue, Net Income and Gross profit
  • Figure 28. Moregate Biotech (Australia) Revenue: by Geography 2020
  • Figure 29. VWR International (United States) Revenue, Net Income and Gross profit
  • Figure 30. VWR International (United States) Revenue: by Geography 2020
  • Figure 31. South Pacific Sera (New Zealand) Revenue, Net Income and Gross profit
  • Figure 32. South Pacific Sera (New Zealand) Revenue: by Geography 2020
  • Figure 33. Atlanta Biologicals, Inc. (India) Revenue, Net Income and Gross profit
  • Figure 34. Atlanta Biologicals, Inc. (India) Revenue: by Geography 2020
  • Figure 35. Global Blood Serum: by Type USD Million (2021-2026)
  • Figure 36. Global Blood Serum: by Application USD Million (2021-2026)
  • Figure 37. South America Blood Serum Share (%), by Country
  • Figure 38. Asia Pacific Blood Serum Share (%), by Country
  • Figure 39. Europe Blood Serum Share (%), by Country
  • Figure 40. MEA Blood Serum Share (%), by Country
  • Figure 41. North America Blood Serum Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Sigma-Aldrich (United States)
  • Merck Group (Germany)
  • Corning Inc. (United States)
  • Biological Industries (Israel)
  • Bovogen Biologicals (Australia)
  • Moregate Biotech (Australia)
  • VWR International (United States)
  • South Pacific Sera (New Zealand)
  • Atlanta Biologicals, Inc. (India)
Additional players considered in the study are as follows:
Zhejiang Tianhang Biotechnology Co Ltd (China) , Jin Yuan Kang Industry Co., Ltd. (China)
Select User Access Type

Key Highlights of Report


Jul 2021 204 Pages 91 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Serum Quantitative research analysis
Global Blood Serum Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"High Demand for Numerous Diagnostic Tests " is seen as one of major growth factors of Blood Serum Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
will lead the Blood Serum Market.

Know More About Global Blood Serum Report?

Have a Query? Click Here

Other Related Reports

Pigmented Lesion Treatment Comprehensive Study by Type (Energy Based Devices, RF Devices, Ultrasound Devices, IPL Devices), Application (Dermatology Clinics, Beauty Clinics, Hospitals), Treatment (La...
$ 3650
Stretch Marks Treatment Comprehensive Study by Type (Topical Products (Oils, Creams, and Lotion), Lasers (Pulse-Dye Laser, Fractional Laser, and Others), Microdermabrasion, Others), Application (Hosp...
$ 3450
Animal Genetics Comprehensive Study by Type (Live Animals), Application (Genetic Typing, Genetic Trait Testing, Genetic Disease Testing), Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Tes...
$ 3650
Botulism Treatment Comprehensive Study by Type (Antitoxin, Antibiotics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End User (Hospitals, Specialty Clinics, Others), Bo...
$ 3450
Brain Tumor Treatment Comprehensive Study by Treatment (Surgery, Radiation Therapy, Radiosurgery, Chemotherapy, Targeted Drug Therapy), End-user (Hospitals, Clinics, Ambulatory Surgery Centres), Diag...
$ 3650
Colorectal Cancer Comprehensive Study by Type (Lymphoma, Carcinoids, Turcot Syndrome, Adenocarcinoma, Juvenile Polyposis Coli, Peutz-Jeghers Syndrome (PJS), Familial Colorectal Cancer (FCC), Gastroin...
$ 3750